分享

【速递】每日最新论文快讯精选

 CBG资讯公众号 2020-08-19

# Organic Chemistry #

Visible-Light-Triggered Uncaging of Carbonyl Sulfide for Hydrogen Sulfide (H2S) Release

Organic Letters
September 5, 2017
10.1021/lett.7b02259
Ajay Kumar Sharma†, Mrutyunjay Nair†, Preeti Chauhan†, Kavya Gupta‡, Deepak K Saini‡, and Harinath Chakrapani


Abstract: Generation of hydrogen sulfide (H2S) is challenging and few methods are capable of localized delivery of this gas. Here, a boron dipyrromethene-based carbamothioate (BDP-H2S) that is uncaged by visible light of 470 nm to generate carbonyl sulfide (COS), which is rapidly hydrolyzed to H2S in the presence of carbonic anhydrase, a widely prevalent enzyme, is reported.

Link to CBG:

http://www./news/art?id=7047

Link to the article:

http://pubs./doi/10.1021/lett.7b02259

# Medicinal Chemistry #

Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment

Journal of Controlled Release
5 September 2017
10.1016/j.jconrel.2017.09.003
Chun Y. Wonga, Hani Al-Salamia, b, Crispin R. Dass

Abstract: Nanoparticles have demonstrated significant advancements in potential oral delivery of insulin. In this publication, we review the current status of polymeric, inorganic and solid-lipid nanoparticles designed for oral administration of insulin. Firstly, the structure and physiological function of insulin are examined. Then, the efficiency and shortcomings of insulin nanoparticle are discussed. These include the susceptibility to digestive enzyme degradation, instability in the acidic pH environment, poor mucus diffusion and inadequate permeation through the gastrointestinal epithelium. In order to optimise the nanocarriers, the following considerations, including polymer nature, surface charge, size, polydispersity index and morphology of nanoparticles, have to be taken into account. Some novel designs such as chitosan-based glucose-responsive nanoparticles, layer by layer technique-based nanoparticles and zwitterion nanoparticles are being adopted to overcome the physiological challenges. The review ends with some future directions and challenges to be addressed for the success of oral delivery of insulin-loaded nanoparticle formulation.

Link to CBG:

http://www./news/art?id=7062

Link to the article:

http://www./science/article/pii/S0168365917308283

Medicinal Chemistry #

Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas

Journal of Controlled Release
5 September 2017
10.1016/j.jconrel.2017.09.006
Aniket S. Wadajkar, Jimena G. Dancy, Nathan B. Roberts, Nina P. Connolly, Dudley K. Strickland, Jeffrey A. Winkles, Graeme F. Woodworth , Anthony J. Kim

Abstract: The most common and deadly form of primary brain cancer, glioblastoma (GBM), is characterized by significant intratumoral heterogeneity, microvascular proliferation, immune system suppression, and brain tissue invasion. Delivering effective and sustained treatments to the invasive GBM cells intermixed with functioning neural elements is a major goal of advanced therapeutic systems for brain cancer. Previously, we investigated the nanoparticle characteristics that enable targeting of invasive GBM cells. This revealed the importance of minimizing non-specific binding within the relatively adhesive, ‘sticky’ microenvironment of the brain and brain tumors in particular. We refer to such nanoformulations with decreased non-specific adhesivity and receptor targeting as ‘DART’ therapeutics. In this work, we applied this information toward the design and characterization of biodegradable nanocarriers, and in vivo testing in orthotopic experimental gliomas. We formulated particulate nanocarriers using poly(lactic-co-glycolic acid) (PLGA) and PLGA-polyethylene glycol (PLGA-PEG) polymers to generate sub-100 nm nanoparticles with minimal binding to extracellular brain components and strong binding to the Fn14 receptor – an upregulated, conserved component in invasive GBM. Multiple particle tracking in brain tissue slices and in vivo testing in orthotopic murine malignant glioma revealed preserved nanoparticle diffusivity and increased uptake in brain tumor cells. These combined characteristics also resulted in longer retention of the DART nanoparticles within the orthotopic tumors compared to non-targeted versions. Taken together, these results and nanoparticle design considerations offer promising new methods to optimize therapeutic nanocarriers for improving drug delivery and treatment for invasive brain tumors.

Link to CBG:

http://www./news/art?id=7061

Link to the article:

http://www./science/article/pii/S0168365917308295

了解更多最全、最新论文快讯

登录CBG官网(www.

下载ChemBeanGo APP

CBG资讯 知识就是力量

    转藏 分享 献花(0

    0条评论

    发表

    请遵守用户 评论公约

    类似文章